Copyright
©The Author(s) 2018.
World J Gastroenterol. Oct 14, 2018; 24(38): 4403-4411
Published online Oct 14, 2018. doi: 10.3748/wjg.v24.i38.4403
Published online Oct 14, 2018. doi: 10.3748/wjg.v24.i38.4403
Figure 3 Trends in liver transplantation before and after direct-acting antiviral introduction.
ALD: Alcoholic liver disease; DAA: Direct-acting antivirals; HBV: Hepatitis B virus; HCV: Hepatitis C virus; HCC: Hepatocellular carcinoma; NASH: Non-alcoholic steatohepatitis.
- Citation: Ferrarese A, Germani G, Gambato M, Russo FP, Senzolo M, Zanetto A, Shalaby S, Cillo U, Zanus G, Angeli P, Burra P. Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study. World J Gastroenterol 2018; 24(38): 4403-4411
- URL: https://www.wjgnet.com/1007-9327/full/v24/i38/4403.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i38.4403